Restricted accessResearch articleFirst published online 2016-08
Differential Expression of SWI/SNF Chromatin Remodeler Subunits Brahma and Brahma-Related Gene During Drug-Induced Liver Injury and Regeneration in Mouse Model
The chromatin remodeling activity of mammalian SWI/SNF complex is carried out by either Brahma (BRM) or Brahma-related gene (BRG-1). The BRG-1 regulates genes involved in cell proliferation, whereas BRM is associated with cell differentiation, and arrest of cell growth. Global modifications of histones and expression of genes of chromatin-remodeling subunits have not been studied in in vivo model systems. In the present study, we investigate epigenetic modifications of histones and the expression of genes in thioacetamide (TAA)-induced liver injury and regeneration in a mouse model. In the present study, we report that hepatocyte proliferation and H3S10 phosphorylation occur during 60 to 72 h post TAA treatment in mice. Furthermore, there was change in the H3K9 acetylation and H3K9 trimethylation pattern with respect to liver injury and regeneration phase. Looking into the expression pattern of Brg-1 and Brm, it is evident that they contribute substantially to the process of liver regeneration. The SWI/SNF remodeler might contain BRG-1 as its ATPase subunit during injury phase. Whereas, BRM-associated SWI/SNF remodeler might probably be predominant during decline of injury phase and initiation of regeneration phase. Furthermore, during the regeneration phase, BRG-1-containing remodeler again predominates. Considering all these observations, the present study depicts an interplay between chromatin interacting machineries in different phases of thioacetamide-induced liver injury and regeneration.
Get full access to this article
View all access options for this article.
References
1.
AlessioN., SquillaroT., CipollaroM., BagellaL., GiordanoA., and GalderisiU. (2010). The BRG1 ATPase of chromatin remodeling complexes is involved in modulation of mesenchymal stem cell senescence through RB-P53 pathways. Oncogene, 29, 5452–5463.
BucherN.L., and SwaffieldM.N. (1973). Regeneration of liver in rats in the absence of portal splanchnic organs and a portal blood supply. Cancer Res, 33, 3189–3194.
4.
BultmanS., GebuhrT., YeeD., La MantiaC., NicholsonJ., GilliamA., RandazzoF., MetzgerD., ChambonP., CrabtreeG., et al. (2000). A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol Cell, 6, 1287–1295.
5.
ChilakapatiJ., ShankarK., KorrapatiM.C., HillR.A., and MehendaleH.M. (2005). Saturation toxicokinetics of thioacetamide: role in initiation of liver injury. Drug Metab Dispos, 33, 1877–1885.
6.
Coisy-QuivyM., DissonO., RoureV., MuchardtC., BlanchardJ.M., and DantonelJ.C. (2006). Role for Brm in cell growth control. Cancer Res, 66, 5069–5076.
7.
DevineJ.H., HewetsonA., LeeV.H., and ChiltonB.S. (1999). After chromatin is SWItched-on can it be RUSHed?. Mol Cell Endocrinol, 151, 49–56.
8.
DunaiefJ.L., StroberB.E., GuhaS., KhavariP.A., AlinK., LubanJ., BegemannM., CrabtreeG.R., and GoffS.P. (1994). The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell, 79, 119–130.
FerrellL. (2000). Liver pathology: cirrhosis, hepatitis, and primary liver tumors. Update and diagnostic problems. Mod Pathol, 13, 679–704.
12.
FischleW., TsengB.S., DormannH.L., UeberheideB.M., GarciaB.A., ShabanowitzJ., HuntD.F., FunabikiH., and AllisC.D. (2005). Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylation. Nature, 438, 1116–1122.
13.
FlowersS., NaglN.G.Jr., BeckG.R.Jr., and MoranE. (2009). Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation. J Biol Chem, 284, 10067–10075.
14.
GorskiK., CarneiroM., and SchiblerU. (1986). Tissue-specific in vitro transcription from the mouse albumin promoter. Cell, 47, 767–776.
15.
HaberB.A., MohnK.L., DiamondR.H., and TaubR. (1993). Induction patterns of 70 genes during nine days after hepatectomy define the temporal course of liver regeneration. J Clin Invest, 91, 1319–1326.
16.
HeH., and LehmingN. (2003). Global effects of histone modifications. Brief Funct Genomic Proteomic, 2, 234–243.
17.
KondoY., ShenL., SuzukiS., KurokawaT., MasukoK., TanakaY., KatoH., MizunoY., YokoeM., SugauchiF., et al. (2007). Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas. Hepatol Res, 37, 974–983.
18.
KouzaridesT. (2007). Chromatin modifications and their function. Cell, 128, 693–705.
19.
LaemmliU.K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680–685.
20.
MandrekarP. (2011). Epigenetic regulation in alcoholic liver disease. World J Gastroenterol, 17, 2456–2464.
21.
MangipudyR.S., ChandaS., and MehendaleH.M. (1995). Tissue repair response as a function of dose in thioacetamide hepatotoxicity. Environ Health Perspect, 103, 260–267.
MichalopoulosG.K., and DeFrancesM.C. (1997). Liver regeneration. Science, 276, 60–66.
24.
MohrmannL., and VerrijzerC.P. (2005). Composition and functional specificity of SWI2/SNF2 class chromatin remodeling complexes. Biochim Biophys Acta, 1681, 59–73.
25.
MuchardtC., BourachotB., ReyesJ.C., and YanivM. (1998). ras transformation is associated with decreased expression of the brm/SNF2alpha ATPase from the mammalian SWI-SNF complex. EMBO J, 17, 223–231.
26.
MuchardtC., ReyesJ.C., BourachotB., LeguoyE., and YanivM. (1996). The hbrm and BRG-1 proteins, components of the human SNF/SWI complex, are phosphorylated and excluded from the condensed chromosomes during mitosis. EMBO J, 15, 3394–3402.
27.
MuchardtC., and YanivM. (1999a). ATP-dependent chromatin remodelling: SWI/SNF and Co. are on the job. J Mol Biol, 293, 187–198.
28.
MuchardtC., and YanivM. (1999b). The mammalian SWI/SNF complex and the control of cell growth. Semin Cell Dev Biol, 10, 189–195.
29.
NaitoM., ZagerR.A., and BomsztykK. (2009). BRG1 increases transcription of proinflammatory genes in renal ischemia. J Am Soc Nephrol, 20, 1787–1796.
30.
NielsenS.J., SchneiderR., BauerU.M., BannisterA.J., MorrisonA., O'CarrollD., FiresteinR., ClearyM., JenuweinT., HerreraR.E., et al. (2001). Rb targets histone H3 methylation and HP1 to promoters. Nature, 412, 561–565.
31.
NostrantT.T., MillerD.L., AppelmanH.D., and GumucioJ.J. (1978). Acinar distribution of liver cell regeneration after selective zonal injury in the rat. Gastroenterology, 75, 181–186.
PalmesD., and SpiegelH.U. (2004). Animal models of liver regeneration. Biomaterials, 25, 1601–1611.
34.
PopperH. (1972). The pathology of viral hepatitis. Can Med Assoc J, 106: Suppl, 447–452.
35.
RamadoriG., MoriconiF., MalikI., and DudasJ. (2008). Physiology and pathophysiology of liver inflammation, damage and repair. J Physiol Pharmacol, 59Suppl 1, 107–117.
36.
ReinhardtH.C., and YaffeM.B. (2013). Phospho-Ser/Thr-binding domains: navigating the cell cycle and DNA damage response. Nat Rev Mol Cell Biol, 14, 563–580.
37.
ReyesJ.C., BarraJ., MuchardtC., CamusA., BabinetC., and YanivM. (1998). Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha). EMBO J, 17, 6979–6991.
38.
ReyesJ.C., MuchardtC., and YanivM. (1997). Components of the human SWI/SNF complex are enriched in active chromatin and are associated with the nuclear matrix. J Cell Biol, 137, 263–274.
39.
RuthenburgA.J., LiH., PatelD.J., and AllisC.D. (2007). Multivalent engagement of chromatin modifications by linked binding modules. Nat Rev Mol Cell Biol, 8, 983–994.
40.
Santoni-RugiuE., JelnesP., ThorgeirssonS.S., and BisgaardH.C. (2005). Progenitor cells in liver regeneration: molecular responses controlling their activation and expansion. APMIS, 113, 876–902.
41.
SchmittgenT.D., and LivakK.J. (2008). Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc, 3, 1101–1108.
42.
SchnitzlerG.R., SifS., and KingstonR.E. (1998). A model for chromatin remodeling by the SWI/SNF family. Cold Spring Harb Symp Quant Biol, 63, 535–543.
43.
SchottaG., LachnerM., PetersA.H., and JenuweinT. (2004). The indexing potential of histone lysine methylation. Novartis Found Symp, 259, 22–37; discussion 37–47, 163–169.
44.
SchuppanD., and AfdhalN.H. (2008). Liver cirrhosis. Lancet, 371, 838–851.
45.
SherlockS. (1968). Diseases of the Liver and Biliary System, 4th edition (Blackwell Scientific Publications, Oxford, U.K.).
46.
SherlockS. (1984). Chronic hepatitis and cirrhosis. Hepatology, 4, 25S–28S.
47.
ShiS.R., KeyM.E., and KalraK.L. (1991). Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem, 39, 741–748.
48.
SifS., StukenbergP.T., KirschnerM.W., and KingstonR.E. (1998). Mitotic inactivation of a human SWI/SNF chromatin remodeling complex. Genes Dev, 12, 2842–2851.
49.
SimsR.J.3rd, NishiokaK., and ReinbergD. (2003). Histone lysine methylation: a signature for chromatin function. Trends Genet, 19, 629–639.
50.
SongN., LiuJ., AnS., NishinoT., HishikawaY., and KojiT. (2011). Immunohistochemical Analysis of Histone H3 Modifications in Germ Cells during Mouse Spermatogenesis. Acta Histochem Cytochem, 44, 183–190.
51.
SquillaroT., SeverinoV., AlessioN., FarinaA., Di BernardoG., CipollaroM., PelusoG., ChamberyA., and GalderisiU. (2015). De-regulated expression of the BRG1 chromatin remodeling factor in bone marrow mesenchymal stromal cells induces senescence associated with the silencing of NANOG and changes in the levels of chromatin proteins. Cell Cycle, 14, 1315–1326.
52.
StrobeckM.W., ReismanD.N., GunawardenaR.W., BetzB.L., AngusS.P., KnudsenK.E., KowalikT.F., WeissmanB.E., and KnudsenE.S. (2002). Compensation of BRG-1 function by Brm: insight into the role of the core SWI-SNF subunits in retinoblastoma tumor suppressor signaling. J Biol Chem, 277, 4782–4789.
53.
StukenbergP.T., LustigK.D., McGarryT.J., KingR.W., KuangJ., and KirschnerM.W. (1997). Systematic identification of mitotic phosphoproteins. Curr Biol, 7, 338–348.
54.
SturgillM.G., and LambertG.H. (1997). Xenobiotic-induced hepatotoxicity: mechanisms of liver injury and methods of monitoring hepatic function. Clin Chem, 43, 1512–1526.
55.
SudarsanamP., and WinstonF. (2000). The Swi/Snf family nucleosome-remodeling complexes and transcriptional control. Trends Genet, 16, 345–351.
TaubR., GreenbaumL.E., and PengY. (1999). Transcriptional regulatory signals define cytokine-dependent and -independent pathways in liver regeneration. Semin Liver Dis, 19, 117–127.
58.
TieF., B.R., ConradP.A., ScacheriP.C., and HarteP.J. (2012). Histone demethylase UTX and chromatin remodeler BRM bind directly to CBP and modulate acetylation of histone H3 lysine 27. Mol Cell Biol, 32, 2323–2334.
59.
WagschalA., DelavalK., PannetierM., ArnaudP., and FeilR. (2007a). Chromatin immunoprecipitation (ChIP) on unfixed chromatin from cells and tissues to analyze histone modifications. CSH Protoc, 2007, pdb prot4767.
60.
WagschalA., DelavalK., PannetierM., ArnaudP., and FeilR. (2007b). PCR-based analysis of immunoprecipitated chromatin. CSH Protoc, 2007, pdb prot4768.
61.
WangX., CampoliM., ChoH.S., OginoT., BandohN., ShenJ., HurS.Y., KageshitaT., and FerroneS. (2005). A method to generate antigen-specific mAb capable of staining formalin-fixed, paraffin-embedded tissue sections. J Immunol Methods, 299, 139–151.
62.
WarisG., and SiddiquiA. (2003). Regulatory mechanisms of viral hepatitis B and C. J Biosci, 28, 311–321.
63.
WorkmanJ.L., and KingstonR.E. (1998). Alteration of nucleosome structure as a mechanism of transcriptional regulation. Annu Rev Biochem, 67, 545–579.
64.
WuC.Y., F.X., and WeiL.N. (2014). Coordinated repressive chromatin-remodeling of Oct4 and Nanog genes in RA-induced differentiation of embryonic stem cells involves RIP140. Nucleic Acids Res, 42, 4306–4317.
65.
YuC.C., WoodsA.L., and LevisonD.A. (1992). The assessment of cellular proliferation by immunohistochemistry: a review of currently available methods and their applications. Histochem J, 24, 121–131.
66.
YunM., WuJ., WorkmanJ.L., and LiB. (2011). Readers of histone modifications. Cell Res, 21, 564–578.
67.
ZhangB., ChambersK.J., FallerD.V., and WangS. (2007). Reprogramming of the SWI/SNF complex for co-activation or co-repression in prohibitin-mediated estrogen receptor regulation. Oncogene, 26, 7153–7157.
68.
ZhangJ., OhtaT., MaruyamaA., HosoyaT., NishikawaK., MaherJ.M., ShibaharaS., ItohK., and YamamotoM. (2006). BRG1 interacts with Nrf2 to selectively mediate HO-1 induction in response to oxidative stress. Mol Cell Biol, 26, 7942–7952.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
